Rabu , 17 Mar 2021 15:46:12
Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission


Control of Mycobacterium tuberculosis (Mtb) transmission in high-income health care settings and in low tuberculosis (TB) prevalence countries remains a public health priority given the constant changes in Mtb epidemiology worldwide. Though Europe is a low prevalence area [1], TB burden among precarious and migrant populations contributes to this evolving landscape, as addressed by the action framework towards TB elimination [2]. At the core of the national health-care system, tertiary care hospitals manage both patients with greater susceptibility to TB, and patients with complex and/or advanced TB disease. Key measures for TB control rely on enabling linkage of cases and identification of transmission chains, often supported by molecular survey tools [3, 4].

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Genestet reports grants from LABEX ECOFECT (ANR-11-LABX-0048) of Lyon University, within the program “Investissements d'Avenir” (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR), during the conduct of the study.

Conflict of interest: Dr. Paret has nothing to disclose.

Conflict of interest: Mrs. Pichat has nothing to disclose.

Conflict of interest: Mr. Berland has nothing to disclose.

Conflict of interest: Dr. Jacomo has nothing to disclose.

Conflict of interest: Dr. Carret has nothing to disclose.

Conflict of interest: Dr. Fredenucci has nothing to disclose.

Conflict of interest: Dr. Hodille has nothing to disclose.

Conflict of interest: Dr. Rasigade has nothing to disclose.

Conflict of interest: Dr. Boisset has nothing to disclose.

Conflict of interest: Dr. Carricajo has nothing to disclose.

Conflict of interest: Pr. Lina has nothing to disclose.

Conflict of interest: Dr. Ronnaux-Baron has nothing to disclose.

Conflict of interest: Dr. Mornex has nothing to disclose.

Conflict of interest: Dr. Grando has nothing to disclose.

Conflict of interest: Dr. Sénéchal has nothing to disclose.

Conflict of interest: Pr. Ader has nothing to disclose.

Conflict of interest: Dr. Dumitrescu has nothing to disclose.

  • Received September 23, 2019.
  • Accepted November 16, 2019.